Skip to main navigation

Main Menu
About
Science
PRODUCTS
Responsibility
Stories
Newsroom
Partners
Investors
Careers
Amgen Worldwide

All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags

COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities

All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags

COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities

About
Science
PRODUCTS
Responsibility
Stories
Newsroom
Partners
Investors
Careers

Breadcrumb

Home
Investors
Press Releases

Press Releases

Investors
News & Events
Financials
Pipeline
Stock
ESG
Resources

Year

NEWS RELEASE 01.17.2025

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

NEWS RELEASE 01.08.2025

AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Navbar w/ text

Investors
News & Events
Financials
Pipeline
Stock
ESG
Resources

Earnings

Show all

Q3 2024

Q3 2024 Amgen Earnings Conference Call
AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
Q3 2024 Earnings Presentation 1.3 MB

Data as of:

Minimum 15 minutes delayed. Source: LSEG

Stay Connected With Amgen.

Contact Us Sitemap Privacy Statement Terms of Use

© 1996-2020 Amgen Inc. All Rights Reserved.